Connor, Clark & Lunn Investment Management Ltd.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1596800
VANCOUVER, A1
Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$546,164
-$20,610,735 QoQ
Shares Held
9,545
-97.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#331
of 561 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. BMRN ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in BMRN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $546,164 | 9,545 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $21,156,899 | 390,637 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $22,182,978 | 403,547 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $36,854,160 | 521,349 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $23,432,482 | 356,496 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,171,704 | 116,257 | Shares | Sole | 2024-11-08 | |
| 2023-09-30 | $468,236 | 5,292 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,244,031 | 14,352 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $22,410,513 | 230,466 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $32,899,057 | 317,896 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $17,071,406 | 201,385 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $20,485,546 | 247,201 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $12,020,121 | 155,903 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,174,789 | 13,297 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,513,172 | 71,331 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,727,875 | 20,708 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $588,826 | 7,798 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,226,624 | 25,392 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $692,936 | 9,108 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $952,308 | 7,721 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||